Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: Results and prognostic factors on long-term follow up

Journal of Gastroenterology and Hepatology (Australia)

Volumn 25, Issue 3, 2010, Pages 597-604

  Waki, Koji ^a   Aikata, Hiroshi ^a   Katamura, Yoshio ^a   Kawaoka, Tomokazu ^a   Takaki, Shintaro ^a   Hiramatsu, Akira ^a   Takahashi, Shoichi ^a   Toyota, Naoyuki ^a   Ito, Katsuhide ^a   Chayama, Kazuaki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Hepatocellular carcinoma; Prognosis; Radiofrequency ablation; Recurrence; Survival

Indexed keywords

INDOCYANINE GREEN; CISPLATIN; IODINATED POPPYSEED OIL; MIDAZOLAM; PENTAZOCINE;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CHEMOEMBOLIZATION; CONTROLLED STUDY; FEMALE; FEVER; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; PRIORITY JOURNAL; PROGNOSIS; RADIOFREQUENCY ABLATION; TUMOR GROWTH; TUMOR VOLUME; CANCER CONTROL; CANCER PROGNOSIS; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE FREE SURVIVAL; FOLLOW UP; LIVER NODULE; OVERALL SURVIVAL; RADIOFREQUENCY ABLATION DEVICE; RISK FACTOR; TREATMENT OUTCOME;

EID: 77649226502     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2009.06125.x     Document Type: Article

References (31)

1. Okuda K. Hepatocellular carcinoma: recent progress. Hepatology 1992 15 : 948 963.
2. Okita K. Management of hepatocellular carcinoma in Japan. J. Gastroenterol. 2006 41 : 100 106.
3. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003 362 : 1907 1917.
4. Song TJ, Ip EW, Fong Y. Hepatocellular carcinoma: current surgical management. Gastroenterology 2004 127 : S248 60.
5. Jansen MC, Van Hillegersberg R, Chamuleau RA, Van Delden OM, Gouma DJ, Van Gulik TM. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review. Eur. J. Surg. Oncol. 2005 31 : 331 347.
6. Gough-Palmer AL, Gedroyc WM. Laser ablation of hepatocellular carcinoma-A review. World J. Gastroenterol. 2008 14 : 7170 7174.
7. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999 210 : 655 661.
8. Orlacchio A, Bazzocchi G, Pastorelli D et al. Percutaneous cryoablation of small hepatocellular carcinoma with US guidance and CT monitoring: initial experience. Cardiovasc. Interv. Radiol. 2008 31 : 587 594.
9. Shiina S, Teratani T, Obi S et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005 129 : 122 130.
10. Yamashiki N, Kato T, Bejarano PA et al. Histopathological changes after microwave coagulation therapy for patients with hepatocellular carcinoma: review of 15 explanted livers. Am. J. Gastroenterol. 2003 98 : 2052 2059.
11. Huang GT, Lee PH, Tsang YM et al. Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study. Ann. Surg. 2005 242 : 36 42.
12. Lencioni R, Llovet JM. Percutaneous ethanol injection for hepatocellular carcinoma: alive or dead? J. Hepatol. 2005 43 : 377 380.
13. Kitamoto M, Imagawa M, Yamada H et al. Radiofrequency ablation in the treatment of small hepatocellular carcinomas: comparison of the radiofrequency effect with and without chemoembolization. AJR Am. J. Roentgenol. 2003 181 : 997 1003.
14. Buscarini L, Buscarini E, Di Stasi M, Vallisa D, Quaretti P, Rocca A. Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur. Radiol. 2001 11 : 914 921.
15. Tateishi R, Shiina S, Teratani T et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005 103 : 1201 1209. (Pubitemid 40328091)
16. Hayashi M, Matsui O, Ueda K, Kawamori Y, Gabata T, Kadoya M. Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material. Radiology 2002 225 : 143 149.
17. Lim JH, Choi D, Kim SH et al. Detection of hepatocellular carcinoma: value of adding delayed phase imaging to dual-phase helical CT. AJR Am. J. Roentgenol. 2002 179 : 67 73.
18. Spreafico C, Marchiano A, Mazzaferro V et al. Hepatocellular carcinoma in patients who undergo liver transplantation: sensitivity of CT with iodized oil. Radiology 1997 203 : 457 460.
19. Goldberg SN, Grassi CJ, Cardella JF et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 2005 235 : 728 739.
20. Lencioni R, Cioni D, Crocetti L et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005 234 : 961 967. (Pubitemid 40250844)
21. Machi J, Bueno RS, Wong LL. Long-term follow-up outcome of patients undergoing radiofrequency ablation for unresectable hepatocellular carcinoma. World J. Surg. 2005 29 : 1364 1373.
22. Raut CP, Izzo F, Marra P et al. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Ann. Surg. Oncol. 2005 12 : 616 628.
23. Choi D, Lim HK, Rhim H et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur. Radiol. 2007 17 : 684 692.
24. Lu DS, Raman SS, Limanond P et al. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J. Vasc. Interv. Radiol. 2003 14 : 1267 1274.
25. Chen MH, Yang W, Yan K et al. The role of contrast-enhanced ultrasound in planning treatment protocols for hepatocellular carcinoma before radiofrequency ablation. Clin. Radiol. 2007 62 : 752 760.
26. Fujioka C, Horiguchi J, Ishifuro M et al. A feasibility study: evaluation of radiofrequency ablation therapy to hepatocellular carcinoma using image registration of preoperative and postoperative CT. Acad. Radiol. 2006 13 : 986 994.
27. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-termresults of treatment and prognostic factors. Ann. Surg. 1999 229 : 216 222.
28. Shimada M, Takenaka K, Gion T et al. Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology 1996 111 : 720 726.
29. Jeong S, Aikata H, Katamura Y et al. Low-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of hepatocellular carcinoma. World J. Gastroenterol. 2007 13 : 5188 5195.
30. Jeong SC, Aikata H, Katamura Y et al. Effects of a 24-week course of interferon-alpha therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma. World J. Gastroenterol. 2007 13 : 5343 5350. (Pubitemid 47559465)
31. Muto Y, Moriwaki H, Ninomiya M et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. N. Engl. J. Med. 1996 334 : 1561 1567. (Pubitemid 26177483)